Wednesday, 26 August 2026European Markets
ExploreSearch
ViaNews EU
stockMarket

BENEVOLENTAI Stock Went Down By Over 20% In The Last 10 Sessions

Loading stream...

(VIANEWS) - Shares of BENEVOLENTAI (AEX-Index: BAI.AS) dropped by a staggering 20.11% in 10 sessions from €3.48 to €2.78 at 13:09 EST on Thursday, after two successive sessions in a row of losses. AEX-Index is jumping 0.12% to €757.57, after four consecutive sessions in a row of losses.

BENEVOLENTAI's last close was €3.00, 70% below its 52-week high of €10.00.

About BENEVOLENTAI

BenevolentAI société anonyme operates as a clinical-stage AI-enabled drug discovery company. The company's BenevolentAI platform powers a pipeline of approximately 20 drug programs. BenevolentAI société anonyme was formerly known as BenevolentAI Limited and changed its name to BenevolentAI société anonyme on April 22, 2022. The company is headquartered in London, United Kingdom.

More news about BENEVOLENTAI (BAI.AS).

Categories

stockMarket

Tags

Stock PricePrice DownMarket Session NowStock Price DownStock Market NowMarket SessionStock MarketBAI.ASStockBENEVOLENTAI
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com